Our results offer additional confirmation to our speculation that MDM2 can shift the balance of the intracellular events in cancer cells towards pro-angiogenic mechanisms through up-regulation of TNF-α, MMP9, and CXCL10. This evidence concerns the gene MDM2 and cancer.